Slow-K 600mg Tablet

Slow-K 600mg Tablet is a prolonged-release potassium chloride tablet with a slow-release system designed to release potassium gradually. Each tablet contains 600mg of potassium chloride, equivalent to approximately 315mg or 8 mEq of potassium ion. It is an oral medicine whose dosing should be determined from the individual’s clinical needs and potassium monitoring rather than from the tablet strength alone.

It is most appropriate for patients who have been advised by a healthcare professional to take potassium supplementation and who can swallow a prolonged-release tablet safely. Particular caution is required in people with kidney impairment or conditions and medicines that can increase blood potassium. The tablet should be swallowed whole and should not be crushed, chewed or broken.

Swallow the tablet whole with a full glass of water. Do not chew, crush or break the tablet because doing so can interfere with the prolonged-release formulation. Follow the dosing schedule given by your doctor or pharmacist, and take it at a consistent time if instructed.

There is no single universal dose for Slow-K; the required amount depends on the individual’s potassium level, clinical condition, kidney function and other medicines. The cited clinical guidance lists potassium chloride sustained-release tablets at 1.2–1.8 g/day for hypokalaemia management, while the patient leaflet requires the prescribed dose to be followed. Do not start, stop or change the dose without professional advice.

The shelf life of Slow-K 600mg Tablet is 5 years when stored as recommended. Do not use the tablets after the expiry date shown on the packaging.

Do not store above 30°C. Keep the container tightly closed to protect the tablets from moisture. Keep out of reach of children and use only before the expiry date shown on the packaging.

• Do not use in people with significant hyperkalaemia.
• Do not use when there is severe renal impairment unless specifically managed by a clinician.
• Do not use in patients with conditions where potassium retention is clinically significant unless prescribed and monitored.
• Do not take if you have a known hypersensitivity to potassium chloride or an excipient.

• ACE inhibitors, angiotensin II receptor blockers and potassium-sparing diuretics can increase blood potassium and require professional monitoring.
• NSAIDs may reduce renal potassium excretion and can increase the risk of hyperkalaemia in susceptible patients.
• Digoxin and some medicines affecting cardiac conduction require careful management when potassium levels change.
• Tell your doctor or pharmacist about all prescription medicines, OTC medicines and supplements before starting potassium chloride.

• Swallow each tablet whole with plenty of water.
• Do not crush, chew or split the prolonged-release tablet.
• Take only the dose prescribed or advised after potassium results have been considered.
• Tell your clinician if you have kidney disease or take medicines that affect potassium.
• Do not add potassium supplements or potassium-containing salt substitutes without professional advice.
• Seek urgent help if marked weakness, palpitations or an abnormal heartbeat occurs.

Precautions: Pregnancy and breastfeeding should be discussed with a doctor. Kidney impairment, dehydration, diabetes and medicines affecting potassium require particular attention. Regular blood tests may be needed to monitor potassium and kidney function.

When to See a Doctor or Pharmacist: Seek prompt advice if you have persistent vomiting or diarrhoea, severe abdominal pain, marked weakness, tingling, palpitations or an irregular heartbeat. Do not self-adjust the dose based on how you feel.